Free Trial

Oberweis Asset Management Inc. Has $22.49 Million Stake in Genpact Limited (NYSE:G)

Genpact logo with Business Services background

Oberweis Asset Management Inc. raised its stake in Genpact Limited (NYSE:G - Free Report) by 18.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 523,600 shares of the business services provider's stock after purchasing an additional 81,200 shares during the quarter. Genpact comprises about 1.1% of Oberweis Asset Management Inc.'s investment portfolio, making the stock its 16th biggest position. Oberweis Asset Management Inc. owned 0.30% of Genpact worth $22,489,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently modified their holdings of G. Coppell Advisory Solutions LLC lifted its holdings in Genpact by 529.5% in the 4th quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock worth $25,000 after buying an additional 503 shares in the last quarter. SRH Advisors LLC acquired a new position in Genpact during the 4th quarter worth $26,000. Atlas Capital Advisors Inc. increased its position in shares of Genpact by 55.8% in the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after purchasing an additional 216 shares during the last quarter. Manchester Capital Management LLC acquired a new stake in shares of Genpact in the 4th quarter valued at about $38,000. Finally, GeoWealth Management LLC grew its stake in Genpact by 199.0% during the 4th quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock worth $38,000 after buying an additional 583 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently commented on G. Jefferies Financial Group upgraded shares of Genpact from a "hold" rating to a "buy" rating and upped their price target for the stock from $44.00 to $55.00 in a research report on Tuesday, January 21st. Mizuho raised their price target on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. TD Cowen raised Genpact from a "hold" rating to a "buy" rating and increased their price objective for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Finally, Needham & Company LLC raised their target price on Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Five analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $50.38.

View Our Latest Research Report on Genpact

Insider Activity

In related news, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now directly owns 310,246 shares in the company, valued at $15,167,926.94. The trade was a 4.20 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 2.80% of the company's stock.

Genpact Price Performance

NYSE:G traded up $0.63 during midday trading on Tuesday, hitting $48.89. 399,739 shares of the stock were exchanged, compared to its average volume of 1,455,308. The company has a market capitalization of $8.59 billion, a price-to-earnings ratio of 17.21, a P/E/G ratio of 1.84 and a beta of 1.06. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. Genpact Limited has a one year low of $30.38 and a one year high of $56.76. The business has a 50-day moving average price of $49.76 and a two-hundred day moving average price of $46.42.

Genpact (NYSE:G - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. Sell-side analysts predict that Genpact Limited will post 3.21 EPS for the current year.

Genpact Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.39%. This is an increase from Genpact's previous quarterly dividend of $0.15. The ex-dividend date of this dividend was Tuesday, March 11th. Genpact's dividend payout ratio is presently 23.94%.

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

See Also

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Massive Buybacks: 3 Stocks Insiders Are Buying Up

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines